Neurovalens Ltd raised £6 million (US$8 million) in an investment round for its non-invasive neurostimulation devices, which treat insomnia and manage anxiety. The company will use the funds to expand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results